Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil, a ...

Shares of Merck & Co. Inc. dropped 8%, or $8.18, to $91.61 Tuesday in premarket trading. The creation of a Texas Cyber Command that would partner with the University of Texas at ...

Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.